Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen How who wrote (1032)	6/22/1998 12:21:00 PM
From: Jim Roof	Read Replies (1) of 1432

Steve, Did you ever reach a conclusion as to whether or not the phase III data supported Crossen's report that the Hextend patients used on average one liter less whole blood than did the patients who received the generic? This, if true - and regardless of the mechanism, is a major point in favor of Hextend. And, BTW, scientists still do not know how aspirin works all of its benefits. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next